Trial Profile
A Randomized Controlled Trial of the Effectiveness of Liposomal Bupivacaine (Exparel) When Compared to Local Injection of Bupivacaine After Thoracoscopy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Feb 2021
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary) ; Bupivacaine
- Indications Postoperative pain
- Focus Therapeutic Use
- Acronyms VATS Exparel
- 13 Aug 2019 Status changed from active, no longer recruiting to completed.
- 26 Sep 2018 Results comparing Exparel vs. Bupivicaine for Postoperative Analgesia were presented at the 19th World Conference on Lung Cancer.
- 09 Feb 2018 Planned End Date changed from 1 May 2017 to 1 Jun 2018.